Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Poliovirus vaccination: a trilogy

H Faden1

  • 1State University of New York School of Medicine, Buffalo.

The Journal of Infectious Diseases
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

The new enhanced potency inactivated poliovirus vaccine (IPV) combined with oral poliovirus vaccine (OPV) offers improved immunity against polio. This strategy reduces vaccine-associated paralytic polio while maintaining mucosal protection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of acute otitis media and its relation to clinical features and nasopharyngeal colonization at the time of diagnosis.

Acta oto-laryngologica·2002
Same author

A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides.

Immunological investigations·2001
Same author

The microbiologic and immunologic basis for recurrent otitis media in children.

European journal of pediatrics·2001
Same author

Urinary findings in asymptomatic subjects with spina bifida treated with intermittent catheterization.

The Pediatric infectious disease journal·2001
Same author

Community-acquired methicillin-resistant Staphylococcus aureus and intrafamily spread of pustular disease.

The Pediatric infectious disease journal·2001
Same author

Vaccination strategies for mucosal immune responses.

Clinical microbiology reviews·2001

Area of Science:

  • Vaccinology
  • Infectious Diseases
  • Public Health

Background:

  • Polio incidence dramatically reduced by inactivated (IPV) and oral poliovirus vaccines (OPV).
  • Wild poliovirus remains a concern in developing nations due to low OPV seroconversion rates.
  • All reported paralytic poliomyelitis cases in the US are vaccine-associated.

Purpose of the Study:

  • To evaluate a combined vaccine schedule using enhanced potency IPV and OPV.
  • To reduce vaccine-associated paralytic polio.
  • To retain mucosal protection against polioviruses.

Main Methods:

  • Utilized enhanced potency inactivated poliovirus vaccine (IPV).
  • Administered a schedule of two doses of enhanced potency IPV followed by two doses of OPV.

Related Experiment Videos

  • Assessed systemic and local immunity against polioviruses 1, 2, and 3.

    • Main Results:

    • The combined vaccine schedule demonstrated excellent systemic immunity.
    • The schedule provided robust local immunity against polioviruses.
    • This approach is suggested to offer significant protection.

    Conclusions:

    • A combined schedule of two enhanced potency IPV doses followed by two OPV doses provides excellent immunity.
    • This strategy can reduce vaccine-associated paralytic polio.
    • The schedule effectively retains mucosal protection against poliovirus types 1, 2, and 3.